Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II etravirine study in Friedreich's ataxia
2019-002618-38Phase 2Completed
- Sponsor
- La Nostra Famiglia
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of etravirine in Friedreich ataxia (FA) (2 arms), sponsored by La Nostra Famiglia. Primary endpoints: Safety based on non-severe adverse events, Serious adverse events related to investigational drug and 1 more. Started Jun 2021; status: completed.
02
Drugs
etravirine
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2019-002618-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002618-38.